Delvenne,P. et al. (2004) Epithelial metaplasia: An inadequate environment for antitumour immunity? Trends Immunol., 25, 169-173.
Bosch,F.X. et al. (1995) Prevalence of human papillomavirus in cervical-cancer - a worldwide perspective. J. Natl Cancer Inst., 87, 796-802.
Giannini,S.L. et al. (2002) Influence of the mucosal epithelium microenvironment on Langerhans cells: Implications for the development of squamous intraepithelial lesions of the cervix. Int. J. Cancer, 97, 654-659.
Al-Saleh,W. et al. (1995) Inverse modulation of intraepithelial Langerhans cells and stromal macrophage dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch. Int. J. Pathol., 427, 41-48.
Kripke,M.L. et al. (1990) Evidence that cutaneous antigen-presenting cells migrate to regional lymph-nodes during contact sensitization. J. Immunol., 145, 2833-2838,
Tang,A.M. et al. (1993) Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature, 361, 82-85.
Hodivala,K.J. et al. (1994) Evidence that Cadherins play a role in the down-regulation of integrin expression that occurs during keratmocyte terminal differentiation. J. Cell Biol., 124, 589-600.
Hubert,P. et al. (2005) E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is detective in cervical human papillomavirus-associated (pre)neoplastic lesions. J. Pathol., 206, 346-355.
Zur Hausen,H. (2000) Papillomaviruses causing cancer: Evasion from host-cell control in early events in cancinogenesis. J. Natl Cancer Inst., 92, 690-698.
Batsche,E. et al. (1998) RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP2. Mol. Cell. Biol., 18, 3647-3658.
Gage,J.R. et al. (1990) The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV- 16 differ in retinoblastoma protein binding and other properties. J. Virol., 64, 723-730.
Imai,Y. et al. (1991) Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the under-phosphorylated form of retinoblastoma gene product. J. Virol., 65, 4966-4972.
Boyer,S.N. et al. (1996) E7 protein of human papillomavirus- 16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res., 56, 4620-4624.
Gonzalez,S L. et al. (2001) Degradation of the retinoblastoma tumor suppressor by the human papillornavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol., 75, 7583-7591.
Jones,D.L. et al. (1997) Analysis of the p53-mediated G(1) growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol., 71, 2905-2912.
Batlle,E. et al. (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol., 2, 84-89,
Bolos,V. et al. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci., 116 499-511.
Cano,A. et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2, 76-83.
Hajra,K.M. et al. (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res., 62, 1613-1618.
Delvenne,P. et al. (1994) Detection of human papillomaviruses in paraffin-embedded biopsies of cervical intraepithelial lesions - analysis by immunohistochemistry, in-situ hybridization, and the polymerase chain-reaction. Mod. Pathol., 7, 113-119.
Aguilar-Lemarroy,A. et al. (2002) Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene, 21, 165-175.
Hubert,P. et al. (1998) In vitro propagated dendritic cells from patients with human-papilloma virus-associated preneoplastic lesions of the uterine cervix: Use of Flt3 ligand. Cancer Immunol. Immunother., 47, 81-89.
Hubert,P. et al. (1999) Colonization of in vitro-formed cervical human papillomavirus-associated (pre)neoplastic lesions with dendritic cells role of granulocyte/macrophage colony-stimulating factor. Am. J. Pathol., 154, 775-784.
Hubert,P. et al. (2005) Production of large numbers of Langerhans' cells with intraepithelial migration ability in vitro. Exp. Dermatol. 14, 469-477.
Jiang,M. et al. (2002) Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene, 21, 6041-6048.
Tang,S. et al. (2006) The E7 oncoprotein is transtated from spliced E6 I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J. Virol., 80, 4249-4263.
Tang,S. et al. (2006) Short-term induction and long-term suppression of HPV 16 oncogene silencing by RNA interference in cervical cancer cells., Oncogene, 25, 2094-2104.
Andrade,W.N. et al. (1996) A method for tracking the migration of blood lymphocytes. Immunol. Invest., 25, 455-467.
Pebernard,S. et al. (2004) Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation, 72, 103-111.
Sledz,C.A. et al. (2003) Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol., 5, 834-839.
Sledz,C.A. et al. (2004) RNA interference and double-stranded-RNA-activated pathways. Biochem. Soc. Trans., 32, 952-956.
Giarre,M. et al. (2001) Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16(INK4a)-imposed G(1) cell cycle arrest. J. Virol., 75, 4705-4712.
Bremnes, R.M. et al. (2002) The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer, 36, 115-124.
Fearon,E.R. (2003) Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer. Cancer Cell, 3, 307-310.
Kuefer,R. et al. (2003) The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer. Clin. Cancer Res., 9, 6447-6452.
Matthews,K. et al. (2003) Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J. Virol., 77, 8378-8385.
Chellappan,S. et al. (1992) Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl Acad. Sci. USA, 89, 4549-4553.
Phelps,W.C. et al. (1991) Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism. J. Virol., 65, 6922-6930.
Boyer,B. et al. (2000) Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol., 60, 1091-1099.
Martel,C. et al. (1997) Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness. Cell Growth Differ., 8, 165-178.
Herman,L. et al. (2006) MIP3 alpha stimulates the migration of Langerhans cells in models of human papillomavirus (HPV)-associated (pre)neoplastic epithelium. Cancer Immunol. Immunother., 56, 1087-1096.
Hubert,P. et al. (2007) Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo. FASEB J., 21, 2765-2775.
Woodworth,C.D. et al. (1993) Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell-lines. Am. J. Pathol. 142, 1544-1555.
Riethdorf,S. et al. (1998) Expression of the MCPA-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases. Pathobiology, 66, 260-267.